BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33764904)

  • 1. PALLD mutation in a European family conveys a stromal predisposition for familial pancreatic cancer.
    Liotta L; Lange S; Maurer HC; Olive KP; Braren R; Pfarr N; Burger S; Muckenhuber A; Jesinghaus M; Steiger K; Weichert W; Friess H; Schmid R; Algül H; Jost PJ; Ramser J; Fischer C; Quante AS; Reichert M; Quante M
    JCI Insight; 2021 Mar; 6(8):. PubMed ID: 33764904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism.
    Pogue-Geile KL; Chen R; Bronner MP; Crnogorac-Jurcevic T; Moyes KW; Dowen S; Otey CA; Crispin DA; George RD; Whitcomb DC; Brentnall TA
    PLoS Med; 2006 Dec; 3(12):e516. PubMed ID: 17194196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of deleterious palladin mutations in patients with familial pancreatic cancer.
    Klein AP; Borges M; Griffith M; Brune K; Hong SM; Omura N; Hruban RH; Goggins M
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1328-30. PubMed ID: 19336541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole genome sequencing identifies rare germline variants enriched in cancer related genes in first degree relatives of familial pancreatic cancer patients.
    Tan M; Brusgaard K; Gerdes AM; Mortensen MB; Detlefsen S; Schaffalitzky de Muckadell OB; Joergensen MT
    Clin Genet; 2021 Nov; 100(5):551-562. PubMed ID: 34313325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-exome Sequencing Reveals New Potential Susceptibility Genes for Japanese Familial Pancreatic Cancer.
    Takai E; Nakamura H; Chiku S; Kubo E; Ohmoto A; Totoki Y; Shibata T; Higuchi R; Yamamoto M; Furuse J; Shimizu K; Takahashi H; Morizane C; Furukawa T; Yachida S
    Ann Surg; 2022 Apr; 275(4):e652-e658. PubMed ID: 32826389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline mutations in Japanese familial pancreatic cancer patients.
    Takai E; Yachida S; Shimizu K; Furuse J; Kubo E; Ohmoto A; Suzuki M; Hruban RH; Okusaka T; Morizane C; Furukawa T
    Oncotarget; 2016 Nov; 7(45):74227-74235. PubMed ID: 27732944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of germline and somatic mutations in pancreatic adenosquamous carcinoma using whole exome sequencing.
    Ma H; Song B; Guo S; Li G; Jin G
    Cancer Biomark; 2020; 27(3):389-397. PubMed ID: 31958074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRCA2 germline mutations in familial pancreatic carcinoma.
    Hahn SA; Greenhalf B; Ellis I; Sina-Frey M; Rieder H; Korte B; Gerdes B; Kress R; Ziegler A; Raeburn JA; Campra D; Grützmann R; Rehder H; Rothmund M; Schmiegel W; Neoptolemos JP; Bartsch DK
    J Natl Cancer Inst; 2003 Feb; 95(3):214-21. PubMed ID: 12569143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATM mutations in patients with hereditary pancreatic cancer.
    Roberts NJ; Jiao Y; Yu J; Kopelovich L; Petersen GM; Bondy ML; Gallinger S; Schwartz AG; Syngal S; Cote ML; Axilbund J; Schulick R; Ali SZ; Eshleman JR; Velculescu VE; Goggins M; Vogelstein B; Papadopoulos N; Hruban RH; Kinzler KW; Klein AP
    Cancer Discov; 2012 Jan; 2(1):41-6. PubMed ID: 22585167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDKN2A germline mutations in familial pancreatic cancer.
    Bartsch DK; Sina-Frey M; Lang S; Wild A; Gerdes B; Barth P; Kress R; Grützmann R; Colombo-Benkmann M; Ziegler A; Hahn SA; Rothmund M; Rieder H
    Ann Surg; 2002 Dec; 236(6):730-7. PubMed ID: 12454511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence for germline mutations of the LKB1/STK11 gene in familial pancreatic carcinoma.
    Grützmann R; McFaul C; Bartsch DK; Sina-Frey M; Rieder H; Koch R; McCarthy E; Greenhalf W; Neoptolemos JP; Saeger HD; Pilarsky C
    Cancer Lett; 2004 Oct; 214(1):63-8. PubMed ID: 15331174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel hotspot and rare somatic mutation p.A138V, at TP53 is associated with poor survival of pancreatic ductal and periampullary adenocarcinoma patients.
    Saha G; Singh R; Mandal A; Das S; Chattopadhyay E; Panja P; Roy P; DeSarkar N; Gulati S; Ghatak S; Ghosh S; Banerjee S; Roy B; Ghosh S; Chaudhuri D; Arora N; Biswas NK; Sikdar N
    Mol Med; 2020 Jun; 26(1):59. PubMed ID: 32552660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China.
    Yin L; Wei J; Lu Z; Huang S; Gao H; Chen J; Guo F; Tu M; Xiao B; Xi C; Zhang K; Li Q; Wu J; Gao W; Jiang K; Yu J; Miao Y
    JAMA Netw Open; 2022 Feb; 5(2):e2148721. PubMed ID: 35171259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma.
    Shindo K; Yu J; Suenaga M; Fesharakizadeh S; Cho C; Macgregor-Das A; Siddiqui A; Witmer PD; Tamura K; Song TJ; Navarro Almario JA; Brant A; Borges M; Ford M; Barkley T; He J; Weiss MJ; Wolfgang CL; Roberts NJ; Hruban RH; Klein AP; Goggins M
    J Clin Oncol; 2017 Oct; 35(30):3382-3390. PubMed ID: 28767289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial and sporadic pancreatic cancer share the same molecular pathogenesis.
    Norris AL; Roberts NJ; Jones S; Wheelan SJ; Papadopoulos N; Vogelstein B; Kinzler KW; Hruban RH; Klein AP; Eshleman JR
    Fam Cancer; 2015 Mar; 14(1):95-103. PubMed ID: 25240578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic adenocarcinoma with a germline PTEN p.Arg234Gln mutation.
    Uemura S; Matsubayashi H; Kiyozumi Y; Uesaka K; Yamamoto Y; Sasaki K; Abe M; Urakami K; Kusuhara M; Yamaguchi K
    Fam Cancer; 2018 Apr; 17(2):255-259. PubMed ID: 28755079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palladin mutation causes familial pancreatic cancer: absence in European families.
    Slater E; Amrillaeva V; Fendrich V; Bartsch D; Earl J; Vitone LJ; Neoptolemos JP; Greenhalf W
    PLoS Med; 2007 Apr; 4(4):e164. PubMed ID: 17455999
    [No Abstract]   [Full Text] [Related]  

  • 19. Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer.
    Nissim S; Leshchiner I; Mancias JD; Greenblatt MB; Maertens O; Cassa CA; Rosenfeld JA; Cox AG; Hedgepeth J; Wucherpfennig JI; Kim AJ; Henderson JE; Gonyo P; Brandt A; Lorimer E; Unger B; Prokop JW; Heidel JR; Wang XX; Ukaegbu CI; Jennings BC; Paulo JA; Gableske S; Fierke CA; Getz G; Sunyaev SR; Wade Harper J; Cichowski K; Kimmelman AC; Houvras Y; Syngal S; Williams C; Goessling W
    Nat Genet; 2019 Sep; 51(9):1308-1314. PubMed ID: 31406347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer.
    Hu C; Hart SN; Polley EC; Gnanaolivu R; Shimelis H; Lee KY; Lilyquist J; Na J; Moore R; Antwi SO; Bamlet WR; Chaffee KG; DiCarlo J; Wu Z; Samara R; Kasi PM; McWilliams RR; Petersen GM; Couch FJ
    JAMA; 2018 Jun; 319(23):2401-2409. PubMed ID: 29922827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.